European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
The global legal cannabis industry is no longer an emerging market, but a maturing one with established regulatory frameworks, institutional capital, and a growing ecosystem of professional services.
Cannabis Europa has today unveiled a new, fully reimagined, dedicated VIP Experience focused on the needs of senior executives, investors and policymakers shaping the future of Europe’s cannabis industry.
US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all the oxygen out of the room for the last two years.
Late last month, NASDAQ-listed cannabis operator Flora Growth, which once operated one of Colombia’s largest outdoor cultivation facilities, became the latest to exit the cannabis industry, rebranding as an AI-focused digital asset firm ZeroStack Corp.
It is now nearly two months since President Donald Trump surprised the global cannabis industry by signing an executive order to drag the highly-anticipated cannabis rescheduling process out of the bureaucratic swamp.
Welcome to Business of Cannabis’ new research digest, unpacking the latest clinical evidence shaping cannabis therapeutics.
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global report produced in collaboration with Prohibition Partners, the industry-first discovery platform for B2B cannabis.
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis.